162 related articles for article (PubMed ID: 10738317)
1. Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance.
Lamberts R
Microsc Res Tech; 2000 Mar; 48(6):357-66. PubMed ID: 10738317
[TBL] [Abstract][Full Text] [Related]
2. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
Rauws EA
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
[TBL] [Abstract][Full Text] [Related]
3. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
4. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
5. Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa.
Lamberts R; Brunner G; Solcia E
Digestion; 2001; 64(4):205-13. PubMed ID: 11842276
[TBL] [Abstract][Full Text] [Related]
6. Gastric mucosal morphological consequences of acid suppression: a balanced view.
Meuwissen SG; Craanen ME; Kuipers EJ
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):497-510. PubMed ID: 11403542
[TBL] [Abstract][Full Text] [Related]
7. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
Jensen RT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
[TBL] [Abstract][Full Text] [Related]
8. [Gastric mucosa lesions in gastric ulcer disease. Initial study and 1-year follow-up after Helicobacter pylori eradication].
Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Martín de Argila C
Gastroenterol Hepatol; 2000; 23(6):269-74. PubMed ID: 15324621
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with sterigmatocystin, a fungus toxin, enhances the development of intestinal metaplasia of gastric mucosa in Helicobacter pylori-infected Mongolian gerbils.
Ma F; Misumi J; Zhao W; Aoki K; Kudo M
Scand J Gastroenterol; 2003 Apr; 38(4):360-9. PubMed ID: 12739707
[TBL] [Abstract][Full Text] [Related]
10. Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
Brzozowski T; Konturek PC; Kwiecien S; Konturek SJ; Pajdo R; Drozdowicz D; Ptak A; Pawlik M; Stachura J; Pawlik WW; Hahn EG
J Physiol Pharmacol; 2003 Mar; 54(1):33-51. PubMed ID: 12674217
[TBL] [Abstract][Full Text] [Related]
11. Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa.
Chuang CH; Sheu BS; Yang HB; Kao AW; Cheng HC; Yao WJ
J Gastroenterol Hepatol; 2004 Sep; 19(9):988-93. PubMed ID: 15304114
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of gastritis in patients with Helicobacter pylori-positive reflux esophagitis.
Mihara T; Adachi K; Komazawa Y; Yoshida M; Araki A; Maruyama R; Furuta K; Ishihara S; Amano Y; Kinoshita Y
J Gastroenterol Hepatol; 2005 May; 20(5):682-7. PubMed ID: 15853979
[TBL] [Abstract][Full Text] [Related]
13. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?
Kyzekové J; Arlt J; Arltová M
Hepatogastroenterology; 2001; 48(38):594-602. PubMed ID: 11379362
[TBL] [Abstract][Full Text] [Related]
14. Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial.
Lundell L; Havu N; Miettinen P; Myrvold HE; Wallin L; Julkunen R; Levander K; Hatlebakk JG; Liedman B; Lamm M; Malm A; Walan A;
Aliment Pharmacol Ther; 2006 Mar; 23(5):639-47. PubMed ID: 16480403
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori eradication dramatically improves inflammation in the gastric cardia.
Sharma P; Topalovski M; Mayo MS; Sampliner RE; Weston AP
Am J Gastroenterol; 2000 Nov; 95(11):3107-11. PubMed ID: 11095325
[TBL] [Abstract][Full Text] [Related]
16. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.
Zhou L; Sung JJ; Lin S; Jin Z; Ding S; Huang X; Xia Z; Guo H; Liu J; Chao W
Chin Med J (Engl); 2003 Jan; 116(1):11-4. PubMed ID: 12667379
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori eradication and associated changes in the gastric mucosa.
Murakami K; Kodama M; Sato R; Okimoto T; Watanabe K; Fujioka T
Expert Rev Anti Infect Ther; 2005 Oct; 3(5):757-64. PubMed ID: 16207167
[TBL] [Abstract][Full Text] [Related]
18. [Does H. pylori infection or its eradication play a role in gastroeosphageal reflux disease?].
Zerbib F
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):427-31. PubMed ID: 12700499
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori modulation of gastric acid.
Calam J
Yale J Biol Med; 1999; 72(2-3):195-202. PubMed ID: 10780581
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
